NDATOPICALCREAM
Approved
Jul 2009
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
4/8 — Partial
XERESE (acyclovir and hydrocortisone) by Bausch + Lomb is dna polymerase inhibitors [moa]. Approved for herpes simplex virus nucleoside analog dna polymerase inhibitor [epc]. First approved in 2009.
Drug data last refreshed 9h ago · AI intelligence enriched 12h ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
XERESE is a topical cream combining acyclovir (a nucleoside analog DNA polymerase inhibitor) and hydrocortisone for treatment of herpes simplex virus infections. The combination leverages antiviral activity against HSV replication alongside anti-inflammatory corticosteroid action to reduce both viral burden and associated inflammation. It is indicated for localized HSV lesions on the lips and perioral region.
$0.483MPart D
LOE ApproachingProduct is approaching loss of exclusivity with modest Medicare spending, signaling a defensive or declining brand team structure.
Mechanism of Action
DNA Polymerase Inhibitors
Pharmacologic Class:
Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
XERESE currently shows zero linked job openings, reflecting its LOE-approaching status and limited team expansion. Career roles on this product are primarily defensive and focused on maximizing remaining exclusivity period or managing generic transition rather than growth or innovation.
Brand Manager
Worked on XERESE at Bausch + Lomb? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.